Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related CVS
10 Notable Stocks Trading Ex-Dividend Thursday, October 20
Walgreens-Rite Aid Merger Is In Some Trouble Thanks To Kroger
DGI For The DIY: Q3 2016 Recap (Seeking Alpha)
Related RM
Benzinga's Top Upgrades
Benzinga's Volume Movers
Regional Management Corp (RM) CEO Peter Knitzer on Q3 2016 Results - Earnings Call Transcript (Seeking Alpha)

Analysts at Cantor Fitzgerald downgraded CVS (NYSE: CVS) from “buy” to “hold.” The target price for CVS has been lowered from $65 to $62. CVS's shares closed at $59.89 yesterday.

Jefferies downgraded Regional Management (NYSE: RM) from “buy” to “hold.” The target price for Regional Management is set to $29. Regional Management's shares closed at $31.20 yesterday.

Bank of America downgraded Marathon Oil (NYSE: MRO) from “buy” to “neutral.” The target price for Marathon Oil has been lowered from $45 to $42. Marathon Oil's shares closed at $36.88 yesterday.

Analysts at McNicoll Lewis Vlak downgraded ACADIA Pharmaceuticals (NASDAQ: ACAD) from “buy” to “hold.” The target price for ACADIA Pharmaceuticals has been raised from $18 to $20. ACADIA's shares closed at $20.68 yesterday.

Latest Ratings for CVS

Oct 2016UBSInitiates Coverage onBuy
Oct 2016BairdMaintainsOutperform
Oct 2016Bank of AmericaMaintainsBuy

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (ACAD + CVS)

View Comments and Join the Discussion!